Vanguard Group’s Avalo Therapeutics AVTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $833K | Hold |
166,941
| – | – | ﹤0.01% | 3787 |
|
|
2025
Q1 | $1.34M | Buy |
166,941
+1,140
| +0.7% | +$9.13K | ﹤0.01% | 3623 |
|
|
2024
Q4 | $1.23M | Buy |
165,801
+155,433
| +1,499% | +$1.15M | ﹤0.01% | 3697 |
|
|
2024
Q3 | $98.1K | Hold |
10,368
| – | – | ﹤0.01% | 4200 |
|
|
2024
Q2 | $129K | Buy |
+10,368
| New | +$129K | ﹤0.01% | 4206 |
|
|
2023
Q4 | – | Sell |
-91,817
| Closed | -$11.1K | – | 4499 |
|
|
2023
Q3 | $11.1K | Sell |
91,817
-130,256
| -59% | -$15.7K | ﹤0.01% | 4520 |
|
|
2023
Q2 | $78.9K | Hold |
222,073
| – | – | ﹤0.01% | 4409 |
|
|
2023
Q1 | $389K | Hold |
222,073
| – | – | ﹤0.01% | 4189 |
|
|
2022
Q4 | $1.12M | Buy |
222,073
+91
| +0% | +$459 | ﹤0.01% | 3871 |
|
|
2022
Q3 | $736K | Sell |
221,982
-2,848,571
| -93% | -$9.44M | ﹤0.01% | 4094 |
|
|
2022
Q2 | $1.54M | Sell |
3,070,553
-313,641
| -9% | -$157K | ﹤0.01% | 3927 |
|
|
2022
Q1 | $2.45M | Buy |
3,384,194
+4,891
| +0.1% | +$3.55K | ﹤0.01% | 3874 |
|
|
2021
Q4 | $5.74M | Buy |
3,379,303
+32,027
| +1% | +$54.4K | ﹤0.01% | 3526 |
|
|
2021
Q3 | $7.3M | Buy |
3,347,276
+147,067
| +5% | +$321K | ﹤0.01% | 3424 |
|
|
2021
Q2 | $10.5M | Buy |
3,200,209
+511,169
| +19% | +$1.67M | ﹤0.01% | 3173 |
|
|
2021
Q1 | $8.12M | Buy |
2,689,040
+428,357
| +19% | +$1.29M | ﹤0.01% | 3269 |
|
|
2020
Q4 | $5.97M | Buy |
2,260,683
+91,566
| +4% | +$242K | ﹤0.01% | 3280 |
|
|
2020
Q3 | $4.94M | Buy |
2,169,117
+716,783
| +49% | +$1.63M | ﹤0.01% | 3152 |
|
|
2020
Q2 | $3.78M | Buy |
1,452,334
+624,661
| +75% | +$1.62M | ﹤0.01% | 3217 |
|
|
2020
Q1 | $2.05M | Buy |
827,673
+100,463
| +14% | +$249K | ﹤0.01% | 3310 |
|
|
2019
Q4 | $3.92M | Sell |
727,210
-3,724
| -0.5% | -$20.1K | ﹤0.01% | 3250 |
|
|
2019
Q3 | $2.41M | Buy |
730,934
+52,934
| +8% | +$174K | ﹤0.01% | 3389 |
|
|
2019
Q2 | $3.69M | Buy |
678,000
+244,657
| +56% | +$1.33M | ﹤0.01% | 3270 |
|
|
2019
Q1 | $2.53M | Buy |
433,343
+137,545
| +46% | +$803K | ﹤0.01% | 3372 |
|
|
2018
Q4 | $955K | Buy |
295,798
+207,869
| +236% | +$671K | ﹤0.01% | 3574 |
|
|
2018
Q3 | $411K | Buy |
87,929
+8,094
| +10% | +$37.8K | ﹤0.01% | 3881 |
|
|
2018
Q2 | $346K | Sell |
79,835
-78,157
| -49% | -$339K | ﹤0.01% | 3893 |
|
|
2018
Q1 | $678K | Buy |
157,992
+101,031
| +177% | +$434K | ﹤0.01% | 3729 |
|
|
2017
Q4 | $182K | Buy |
56,961
+1,200
| +2% | +$3.83K | ﹤0.01% | 3947 |
|
|
2017
Q3 | $48K | Sell |
55,761
-3,200
| -5% | -$2.76K | ﹤0.01% | 4031 |
|
|
2017
Q2 | $34K | Buy |
58,961
+3,236
| +6% | +$1.87K | ﹤0.01% | 4044 |
|
|
2017
Q1 | $37K | Sell |
55,725
-14,500
| -21% | -$9.63K | ﹤0.01% | 4041 |
|
|
2016
Q4 | $62K | Buy |
+70,225
| New | +$62K | ﹤0.01% | 4010 |
|